The Cleveland Clinic Kidney Biopsy Epidemiological Project

ABSTRACT: Key Points Kidney biopsy registries in the United States are lacking. We provide a multicenter, multistate kidney biopsy database in the United States and identified demographic and clinical trends. Our study catalogs the spectrum of biopsy-proven kidney disease across the Cleveland Clinic enterprise andhighlights the need for a standardized national kidney biopsy registry to bolster glomerular and kidney disease research in the United States. Visual Abstract

Background

The kidney biopsy is the gold standard for diagnosing glomerular diseases. Large-scale, epidemiologic studies describing the prevalence of kidney diseases are lacking, especially in the United States. We aimed to determine the spectrum of biopsy-proven kidney disease across the Cleveland Clinic enterprise.

Met

SUBMITTER: Bobart S 

PROVIDER: S-EPMC9802556 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature